Hydromorphone hydrochloride tablet, used to relieve moderate to severe pain, has an estimated market size of $ 50 mn for the twelve months ending March 2016, according to IMS
With this acquisition, the company will have critical mass in the dermatology/topicals area and catapult to a leading position in this space, says Rajiv Malik, president, Mylan
Anacor will be a strong fit with Pfizer's innovative business, further supporting its strategic focus on inflammation and immunology
The deal positions AMRI as one of the largest independent developers and suppliers of API to the pharmaceutical industry